Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection - Wikidata - wikimedia - TriplyDB

Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection

Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection

http://www.wikidata.org/entity/Q33938093

about

Competitive inhibition of natural antisense Sok-RNA interactions activates Hok-mediated cell killing in Escherichia coli Concurrent growth rate and transcript analyses reveal essential gene stringency in Escherichia coli Hitting bacteria at the heart of the central dogma: sequence-specific inhibition Lactoferrin as a natural immune modulator Plasmid addiction systems: perspectives and applications in biotechnology.Comparative genome-wide analysis of small RNAs of major Gram-positive pathogens: from identification to application Immunological response to peptide nucleic acid and its peptide conjugate targeted to transactivation response (TAR) region of HIV-1 RNA genome.ε/ζ systems: their role in resistance, virulence, and their potential for antibiotic development.Rhesus macaque theta defensins suppress inflammatory cytokines and enhance survival in mouse models of bacteremic sepsis.Antisense growth inhibition of methicillin-resistant Staphylococcus aureus by locked nucleic acid conjugated with cell-penetrating peptide as a novel FtsZ inhibitor.External guide sequences targeting the aac(6')-Ib mRNA induce inhibition of amikacin resistance.Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis.Impact of different cell penetrating peptides on the efficacy of antisense therapeutics for targeting intracellular pathogens.Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications.(99m)Tc-MORF oligomers specific for bacterial ribosomal RNA as potential specific infection imaging agents Tackling antibiotic resistance: a dose of common antisense?Synthetic RNA silencing in bacteria - antimicrobial discovery and resistance breaking.Scenery of Staphylococcus implant infections in orthopedics.Antimicrobial activity of antisense peptide-peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms.Synthetic Nucleic Acid Analogues in Gene Therapy: An Update for Peptide-Oligonucleotide Conjugates.Leaf Extracts of Selected Gardening Trees Can Attenuate Quorum Sensing and Pathogenicity of Pseudomonas aeruginosa PAO1.Targeting essential genes in Salmonella enterica serovar typhimurium with antisense peptide nucleic acid Exploration of Using Antisense Peptide Nucleic Acid (PNA)-cell Penetrating Peptide (CPP) as a Novel Bactericide against Fire Blight Pathogen Erwinia amylovora.Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo.Potent antibacterial antisense peptide-peptide nucleic acid conjugates against Pseudomonas aeruginosa.Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.Molecular dynamics simulations of cyclohexyl modified peptide nucleic acids (PNA).Comparison of microplate and macrodilution methods in time-kill study of new antimicrobial drugs.Erythrocytes as carriers of antisense PNA addressed against HIV-1 gag-pol transframe domain.Inhibition of beta-lactamase-mediated oxacillin resistance in Staphylococcus aureus by a deoxyribozyme.Advances in therapeutic bacterial antisense biotechnology.Inhibition of gene expression and growth of multidrug-resistant Acinetobacter baumannii by antisense peptide nucleic acids.Supplementation transgenic cow's milk containing recombinant human lactoferrin enhances systematic and intestinal immune responses in piglets.

P2860

Q24674178-38074270-684D-45D9-B920-BEAE21CC5D6D Q28475656-735BC51C-4099-438F-8949-DCCFEDD70BF0 Q28756986-1FAB91EB-ACE7-460F-8DF7-B2697C31305E Q34043199-855FE007-F6E3-44A9-8A57-2A4A7B784D71 Q34160193-959D2AA9-739C-4437-9701-975A27CFDA5A Q34160197-3DAFF23B-D664-4309-9590-139B2DDAA4BF Q34167890-489350F6-090A-44BB-8ADE-4F8735796C70 Q34206489-7D94FACB-8B46-418D-B6B8-FF1EBE0AE348 Q34510873-17B3326F-46E6-4BD3-BED4-06ED00180B33 Q35105919-2B786495-282B-4D3A-AFE1-E5B5D198E89E Q35840844-0E8CFD69-381C-4CCB-A4C9-EC633CA9BF82 Q36288672-F6CC558D-5FBE-4449-8DDD-6CA91ACBB918 Q36565579-4D89877E-4844-4508-8069-88EE04CEE8EB Q36824518-0B762007-C27A-4045-838C-400C12FE6294 Q37304150-9154EE7F-A3AC-4754-B71E-39FD6AEF099A Q37323966-3003E13B-B734-486A-968B-FF2DD547A516 Q37937449-F7E6D3FC-14FD-47A1-83A7-FBFFDA99943B Q37955951-A59F1C42-1D3D-46A7-B2BA-C50FD8699B24 Q38289742-41FB0F53-FE62-4C07-87AE-4CCABD63C455 Q39373677-B3DDEBD2-A41B-4CAC-B1FB-16A898D2B0A5 Q40047796-C552FE64-B87F-4635-9F76-C140052C6887 Q41183612-6301D078-1C5C-4A2A-BEA4-2E7BC91AB810 Q41780753-0BEE4F20-BA4F-41C3-B1E8-4D55D3DD02CF Q41892217-B54FCC38-6419-44DA-9C14-EFC6FBCC965C Q42522615-97112F36-634B-4EBC-993D-E5B86623D6E6 Q42549689-C9D8BA60-973F-404E-AEE5-60F97D2BE7E1 Q43189987-628357EF-E0E4-458D-AC6F-AF678C20693E Q44382639-42CB95A3-D749-4272-8026-74110F5868CC Q44612406-ED1610F1-B4EF-4978-9664-8780C2599C61 Q46933455-0348A5AC-5CC2-4E82-AED6-CC8A2B815877 Q47325247-9B71A018-B77E-4F8D-8E9C-ADFF29087105 Q51064638-B68BB9C2-F554-41EF-A9F7-B48A4C014352 Q53639583-AA3CA1B4-BB25-462E-A334-EDC8DEF2DDA4

P2860

Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection

http://www.wikidata.org/entity/Q33938093

description

2005 nî lūn-bûn

@nan

2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Peptide nucleic acid antisense ...... ouse intraperitoneal infection

@ast

Peptide nucleic acid antisense ...... ouse intraperitoneal infection

@en

type

label

Peptide nucleic acid antisense ...... ouse intraperitoneal infection

@ast

Peptide nucleic acid antisense ...... ouse intraperitoneal infection

@en

prefLabel

Peptide nucleic acid antisense ...... ouse intraperitoneal infection

@ast

Peptide nucleic acid antisense ...... ouse intraperitoneal infection

@en

P1433

Q33938093-449F691C-6E5A-4A0D-84B1-6C084708F6B7

P1476

Q33938093-6EA56D05-703C-4426-9C44-10C5427F0D84

P2093

Q33938093-092ABF97-BC0A-4E25-9C0B-122EA9BEE6AC

Q33938093-67780D49-BCC5-491A-9810-F51756955661

Q33938093-7F2D2255-DA6F-4403-8A6C-EA0ABD34F0DB

P2860

Q33938093-02295B90-F59E-4F32-8A84-09C254629CC1

Q33938093-0437AD9B-155F-4C6B-BE9E-BA304DE00840

Q33938093-04A8BA1A-311A-4360-91F2-70A9E30E78C8

Q33938093-04FE5A3A-A961-43AA-8485-0FF805C5632C

Q33938093-16EBB916-1441-43B6-BB42-FBAD74DCF15C

Q33938093-1B588101-6ADF-481A-9047-2FD345D97FC9

Q33938093-1B9A0893-CC47-455C-897A-B6125DC78DC4

Q33938093-20D3134C-D9D9-4F4B-9B18-5659F85615A7

Q33938093-2AF28831-614B-403A-A7EB-BDCAA1AD7036

Q33938093-4313079D-FD5D-4442-BFB4-6E576E34B7E2

P304

Q33938093-A9D181EF-BAA0-4B45-B942-2B5F79159BDE

P31

Q33938093-7333BC95-B49A-42DA-9B10-0E4A4927352C

P356

Q33938093-45F94C50-2542-4C37-B078-587F13719828

P407

Q33938093-4B69B522-7454-4466-9C75-CE1286257BCF

P433

Q33938093-FE8E3235-979E-48FC-86A9-D6A97801E662

P478

Q33938093-B8C29A45-C4D0-44F9-B493-E14C9AB6F84F

P577

Q33938093-5594CEB8-8264-499B-906E-B5CAD85216C8

P5875

Q33938093-B8E07A6E-9FCF-42C3-A3E5-36A2F786DF19

P698

Q33938093-19A5863A-0500-4D15-87A7-D84D802759C0

P932

Q33938093-7060F91F-802D-47FA-B729-C5648F5C0E90

P356

AAC.49.8.3203-3207.2005

P1433

Antimicrobial Agents and Chemotherapy

P1476

Peptide nucleic acid antisense ...... ouse intraperitoneal infection

@en

P2093

Jeffrey K Actor

http://www.w3.org/2001/XMLSchema#string

Xin-Xing Tan

http://www.w3.org/2001/XMLSchema#string

Yin Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Role of the D-alanyl carrier protein in the biosynthesis of D-alanyl-lipoteichoic acid

Regulation of fatty acid biosynthesis in Escherichia coli

Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamate/glutamine cell wall structure, and bacterial replication.

A novel genomic approach identifies bacterial DNA-dependent RNA polymerase as the target of an antibacterial oligodeoxynucleotide, RBL1.

Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA.

A mutant of Escherichia coli defective in the first step of endotoxin biosynthesis.

An Escherichia coli gene (FabZ) encoding (3R)-hydroxymyristoyl acyl carrier protein dehydrase. Relation to fabA and suppression of mutations in lipid A biosynthesis.

Antisense oligonucleotides: basic concepts and mechanisms.

Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis.

Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology.

P304

3203-3207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.49.8.3203-3207.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7696631

http://www.w3.org/2001/XMLSchema#string

P698

16048926

http://www.w3.org/2001/XMLSchema#string

P932

1196239

http://www.w3.org/2001/XMLSchema#string